Alanna Ruddell

Alanna Ruddell

Auto-generated profile, based on publicly available information

Alanna Ruddell

Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JCJarish N. Cohen
Jarish N. Cohen
CGCynthia J. Guidi
Cynthia J. Guidi
ETEric F. Tewalt
Eric F. Tewalt
HQHui Qiao
Hui Qiao
SRSherin Rouhani
Sherin Rouhani
VEVictor H. Engelhard
Victor H. Engelhard
Peripheral immune tolerance is generally thought to result from cross-presentation of tissue-derived proteins by quiescent tissue-resident dendritic cells to self-reactive T cells that have escaped thymic negative selection, leading to anergy or deletion. Recently, we and others have implicated the lymph node (LN) stroma in mediating CD8 T cell peripheral tolerance. We demonstrate that LN-resident lymphatic endothelial cells express multiple peripheral tissue antigens (PTAs) independent of the autoimmune regulator (Aire). They directly present an epitope derived from one of these, the melanocyte-specific protein tyrosinase, to tyrosinase-specific CD8 T cells, leading to their deletion. We also show that other LN stromal subpopulations express distinct PTAs by mechanisms that vary in their Aire dependence. These results establish lymphatic endothelial cells, and potentially other LN-resident cells, as systemic mediators of peripheral immune tolerance.

1 February 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
MHMaria I. Harrell
Maria I. Harrell
BIBrian M. Iritani
Brian M. Iritani
ARAlanna Ruddell
Alanna Ruddell

1 March 2008 in Journal of Immunological Methods
Verified
Journal Article
Closed access
MHMaria I. Harrell
Maria I. Harrell
BIBrian M. Iritani
Brian M. Iritani
ARAlanna Ruddell
Alanna Ruddell

15 May 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PNPaul E. Neiman
Paul E. Neiman
ARAlanna Ruddell
Alanna Ruddell
CJChristine Jasoni
Christine Jasoni
GLGil Loring
Gil Loring
STSandra Jo Thomas
Sandra Jo Thomas
JDJeffrey Delrow
Jeffrey Delrow
The transcriptional effects of deregulated myc gene overexpression are implicated in tumorigenesis in a spectrum of experimental and naturally occurring neoplasms. In follicles of the chicken bursa of Fabricius, myc induction of B-cell neoplasia requires a target cell population present during early bursal development and progresses through preneoplastic transformed follicles to metastatic lymphomas. We developed a chicken immune system cDNA microarray to analyze broad changes in gene expression that occur during normal embryonic B-cell development and during myc -induced neoplastic transformation in the bursa. The number of mRNAs showing at least 3-fold change was greater during myc -induced lymphomagenesis than during normal development, and hierarchical cluster analysis of expression patterns revealed that levels of several hundred mRNAs varied in concert with levels of myc overexpression. A set of 41 mRNAs were most consistently elevated in myc -overexpressing preneoplastic and neoplastic cells, most involved in processes thought to be subject to regulation by Myc. The mRNAs for another cluster of genes were overexpressed in neoplasia independent of myc expression level, including a small subset with the expression signature of embryonic bursal lymphocytes. Overexpression of myc , and some of the genes overexpressed with myc , may be important for generation of preneoplastic transformed follicles. However, expression profiles of late metastatic tumors showed a large variation in concert with myc expression levels, and some showed minimal myc overexpression. Therefore, high-level myc overexpression may be more important in the early induction of these lymphomas than in maintenance of late-stage metastases.

1 December 2003 in The American Journal of Pathology
Verified
Journal Article
Closed access
ARAlanna Ruddell
Alanna Ruddell
PMPau Mezquita
Pau Mezquita
KBKimberly A. Brandvold
Kimberly A. Brandvold
AFAndrew Farr
Andrew Farr
BIBrian M. Iritani
Brian M. Iritani

20 July 2015 in Scientific Reports
Verified
Journal Article
Open access
SGSheila N. Ganti
Sheila N. Ganti
TATina C. Albershardt
Tina C. Albershardt
BIBrian M. Iritani
Brian M. Iritani
ARAlanna Ruddell
Alanna Ruddell
Our previous studies found that B16-F10 melanoma growth in the rear footpad of immunocompetent mice induces marked B cell accumulation within tumor-draining popliteal lymph nodes (TDLN). This B cell accumulation drives TDLN remodeling that precedes and promotes metastasis, indicating a tumor-promoting role for TDLN B cells. Here we show that phenotypic characterization of lymphocytes in mice bearing B16-F10 melanomas identifies preferential accumulation of T2-MZP B cells in the TDLN. Comparison of non-draining LNs and spleens of tumor-bearing mice with LNs and spleens from naïve mice determined that this pattern of B cell accumulation was restricted to the TDLN. B cell-deficient and immunocompetent mice reconstituted with T2-MZP B cells but not with other B cell subsets displayed accelerated tumor growth, demonstrating that T2-MZP B cells possess regulatory activity in tumor-bearing mice. Unlike splenic regulatory B cells, however, these TDLN B cells did not exhibit increased IL-10 production, nor did they promote Treg generation in the TDLN. These findings demonstrate that tumors initially signal via the lymphatic drainage to stimulate the preferential accumulation of T2-MZP regulatory B cells. This local response may be an early and critical step in generating an immunosuppressive environment to permit tumor growth and metastasis.